Addrenex Pharmaceuticals, Inc.

Quick facts

Phase 3 pipeline

• low dose clonidine HCl sustained release · Cardiovascular
  Clonidine HCl works by stimulating alpha-2 adrenergic receptors in the brain, which decreases sympathetic nervous system activity and lowers blood pressure.

Phase 2 pipeline

• ADX415 · Oncology
  ADX415 is a monoclonal antibody targeting CD47.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Addrenex Pharmaceuticals, Inc. portfolio CI brief
• Addrenex Pharmaceuticals, Inc. pipeline updates RSS